Tafasitamab plus lenalidomide in relapsed or refractory diffuse large B-cell lymphoma (L-MIND): a multicentre, prospective, single-arm, phase 2 study.
暂无分享，去创建一个
G. Salles | G. Gaidano | G. Fingerle-Rowson | M. André | M. Dreyling | N. Kalakonda | O. Tournilhac | S. Ambarkhane | A. Liberati | Z. Nagy | W. Jurczak | J. Duell | K. Maddocks | J. Weirather | A. Obr | M. Dirnberger-Hertweck | E. González Barca | E. Gonzalez Barca